| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56 |
| filingDate |
2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107250113-B |
| titleOfInvention |
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator proteins |
| abstract |
The present disclosure relates to compounds comprising N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide ( Co-crystals of compound 1) and co-formers and methods for their preparation. The present disclosure also relates to pharmaceutical compositions comprising co-crystal forms and methods and kits for treatment utilizing the same. |
| priorityDate |
2014-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |